GAD1 and type 1 diabetes mellitus: In the present study, we simultaneously characterized the frequency and phenotype of T cells that recognize enzymatically modified neo-epitopes from GAD and IA2 in subjects with established T1D and examined their cytokine profiles in subjects with type 1 diabetes and at-risk subjects.